Regeneron Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;'>RP</div>
REGN -- USA Stock  

USD 498.84  6.29  1.25%

Regeneron Stock News module provides quick insight into current market opportunities from investing in Regeneron Pharmaceuticals. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Regeneron Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Additionally, take a look at Regeneron Pharmaceuticals Hype Analysis, Regeneron Pharmaceuticals Correlation and Regeneron Pharmaceuticals Performance.

Search Today's Stock News

 
Refresh
Regeneron Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Regeneron daily returns and investor perception about the current pice of Regeneron Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Exercise or conversion by Peter Powchik of 16000 shares of Regeneron Pharmaceuticals subject to Rule 16b-3
Filed transaction by Regeneron Pharmaceuticals officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Regeneron Pharmaceuticals insider trading alert for exercise of common stock by Peter Powchik, SVP Clin Devel Reg Affairs, on December 3, 2019. This event was filed by Regeneron Pharmaceuticals with SEC on 2012-12-20. Statement of changes in beneficial ownership - SEC Form 4. Peter Powchik is currently serves as senior vice president - clinical development of Regeneron Pharmaceuticals

Cash Floor Correlation

Click cells to compare fundamentals   

Gross Profit

Gross Profit Comparative Analysis

Regeneron Pharmaceuticals is currently under evaluation in gross profit category among related companies. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Additionally, take a look at Regeneron Pharmaceuticals Hype Analysis, Regeneron Pharmaceuticals Correlation and Regeneron Pharmaceuticals Performance. Please also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.